Imagenebio, Stock Market Value
| IMA Stock | 6.02 0.12 2.03% |
| Symbol | ImageneBio, |
ImageneBio, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio,. If investors know ImageneBio, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImageneBio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ImageneBio, is measured differently than its book value, which is the value of ImageneBio, that is recorded on the company's balance sheet. Investors also form their own opinion of ImageneBio,'s value that differs from its market value or its book value, called intrinsic value, which is ImageneBio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImageneBio,'s market value can be influenced by many factors that don't directly affect ImageneBio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImageneBio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ImageneBio, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImageneBio,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImageneBio,.
| 10/25/2025 |
| 12/24/2025 |
If you would invest 0.00 in ImageneBio, on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding ImageneBio, or generate 0.0% return on investment in ImageneBio, over 60 days. ImageneBio, is related to or competes with Connect Biopharma, InflaRx NV, Kalaris Therapeutics,, Shattuck Labs, Context Therapeutics, Sutro Biopharma, and Artiva Biotherapeutics,. ImageneBio, is entity of United States. It is traded as Stock on NASDAQ exchange. More
ImageneBio, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImageneBio,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImageneBio, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 15.57 | |||
| Value At Risk | (4.69) | |||
| Potential Upside | 5.0 |
ImageneBio, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImageneBio,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImageneBio,'s standard deviation. In reality, there are many statistical measures that can use ImageneBio, historical prices to predict the future ImageneBio,'s volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (1.96) |
ImageneBio, Backtested Returns
ImageneBio, holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13 % return per unit of risk over the last 3 months. ImageneBio, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ImageneBio,'s Market Risk Adjusted Performance of (1.95), risk adjusted performance of (0.09), and Standard Deviation of 3.03 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, ImageneBio,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding ImageneBio, is expected to be smaller as well. At this point, ImageneBio, has a negative expected return of -0.39%. Please make sure to check out ImageneBio,'s potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if ImageneBio, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.77 |
Good predictability
ImageneBio, has good predictability. Overlapping area represents the amount of predictability between ImageneBio, time series from 25th of October 2025 to 24th of November 2025 and 24th of November 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImageneBio, price movement. The serial correlation of 0.77 indicates that around 77.0% of current ImageneBio, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.77 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
ImageneBio, lagged returns against current returns
Autocorrelation, which is ImageneBio, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImageneBio,'s stock expected returns. We can calculate the autocorrelation of ImageneBio, returns to help us make a trade decision. For example, suppose you find that ImageneBio, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ImageneBio, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImageneBio, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImageneBio, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImageneBio, stock over time.
Current vs Lagged Prices |
| Timeline |
ImageneBio, Lagged Returns
When evaluating ImageneBio,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImageneBio, stock have on its future price. ImageneBio, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImageneBio, autocorrelation shows the relationship between ImageneBio, stock current value and its past values and can show if there is a momentum factor associated with investing in ImageneBio,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImageneBio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio, Stock:Check out ImageneBio, Correlation, ImageneBio, Volatility and ImageneBio, Alpha and Beta module to complement your research on ImageneBio,. For information on how to trade ImageneBio, Stock refer to our How to Trade ImageneBio, Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
ImageneBio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.